0000899243-19-012933.txt : 20190509 0000899243-19-012933.hdr.sgml : 20190509 20190509200124 ACCESSION NUMBER: 0000899243-19-012933 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190507 FILED AS OF DATE: 20190509 DATE AS OF CHANGE: 20190509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tovey Christopher J. CENTRAL INDEX KEY: 0001754163 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35892 FILM NUMBER: 19812475 MAIL ADDRESS: STREET 1: SOVEREIGN HOUSE, VISION PARK, HISTON CITY: CAMBRIDGE STATE: X0 ZIP: CB24 9BZ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001351288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 BUSINESS PHONE: 44 1223 266800 MAIL ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-07 0 0001351288 GW PHARMACEUTICALS PLC GWPH 0001754163 Tovey Christopher J. SOVEREIGN HOUSE, VISION PARK, HISTON CAMBRIDGE X0 CB24 9BZ UNITED KINGDOM 0 1 0 0 Chief Operating Officer Ordinary Shares 2019-05-07 4 M 0 200736 0.0013 A 203239 D Ordinary Shares 2019-05-07 4 S 0 200736 16.14 D 2503 D Stock Options 0.0013 2019-05-07 4 M 0 7 0.00 D 2018-06-24 2025-06-24 Ordinary Shares 7 0 D Stock Options 8.7901 2019-05-07 4 M 0 27924 0.00 D 2018-06-24 2025-06-24 Ordinary Shares 27924 0 D Stock Options 0.0013 2019-05-07 4 M 0 10457 0.00 D 2019-02-15 2026-02-15 Ordinary Shares 10457 0 D Stock Options 0.0013 2019-05-07 4 M 0 139420 0.00 D 2019-02-15 2026-02-15 Ordinary Shares 139420 0 D Stock Options 3.3667 2019-05-07 4 M 0 7508 0.00 D 2019-02-15 2026-02-15 Ordinary Shares 7508 67000 D Stock Options 0.0013 2019-05-07 4 M 0 6468 0.00 D 2019-01-06 2027-01-06 Ordinary Shares 6468 0 D Stock Options 0.0013 2019-05-07 4 M 0 8952 0.00 D 2019-02-26 2028-02-26 Ordinary Shares 8952 0 D Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of May 7, 2019. Represented by ADSs. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2019. The exercise price reported is price per ordinary share converted from price per ADS. /s/ Christopher J. Tovey 2019-05-09